IMPACT Therapeutics grants Pharmanovia exclusive rights to senaparib across 66 countries

Datroway approved in EU for first-line metastatic triple-negative breast cancer

Karyopharm reports topline Phase 3 trial results in endometrial cancer

Proteotype unveils Alchemi platform for blood-based multi-cancer test Enlighten

10x Genomics and Lausanne University Hospital to collaborate on cancer care research

AbCellera and Vertex agree collaboration to develop multispecific T-cell engagers

Hemogenyx partners with Lithuanian cancer centre on HG-CT-1 research and clinical programme

Lantern Pharma advances EMA-cleared Phase 1b/2 bladder cancer trial for LP-184

DifGen Pharmaceuticals' single injection treatment for advanced breast cancer cleared for clinical development

Harbour BioMed and Sinopharm establish innovation R&D consortium

CHMP backs Gilead's Trodelvy-Keytruda combination for first-line metastatic triple-negative breast cancer

Active Biotech doses first patient in amended tasquinimod myelofibrosis study

Bio-Thera Solutions reports first patient dosed in Phase 1 study of BAT8013

EU approves AstraZeneca's Etcamah combination for 1st-line ER-positive advanced breast cancer

BeOne Medicines expands US manufacturing with USD300m investment